Partnership will develop targeted miRNAs to treat pancreatic cancer - Drug Discovery World (DDW)
Schlusswort
Aktuelles
Björn Simon
Mitarbeiter des Rudolf-Boehm-Institutes
Wissenschaftlicher Mitarbeiter (m/w/d) Klinische Pharmakologie - Universität Leipzig, Medizinische Fakultät - academics
SiSaf and the University of Leipzig Partner to Develop
Achim Aigner | Leipzig University, Germany | | Conferenceseries
SiSaf and the University of Leipzig Partner to Develop Bio-Courier Targeted miRNA for the Treatment of Pancreatic Cancer - SiSaf Ltd
Pharmaceutics | Free Full-Text | Amphiphilic Anionic Oligomer-Stabilized Calcium Phosphate Nanoparticles with Prospects in siRNA Delivery via Convection-Enhanced Delivery
Wissenschaftlicher Beirat – Frankfurt Foundation Quality of Medicines
Mitarbeiter des Rudolf-Boehm-Institutes
Mitarbeiter des Rudolf-Boehm-Institutes
Aktuelles
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Nanoparticle-mediated delivery of small RNA molecules in tumor therapy
Pancreatic Cancer Therapy Using miRNA
Traueranzeigen | trauer.op-online.de
Achim Prof. Dr. Aigner – Professor – University of Leipzig, Rudolf-Boehm-Institute for Pharmacology and Toxicology | LinkedIn
Rudolf-Boehm-Institut für Pharmakologie und Toxikologie
Neuartige Gentherapie zur Behandlung des Glioblastoms
Analysis of SATB1 in Head and Neck Squamous Cell Carcinoma
Loop | Achim Aigner
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
